Compare Repligen Corporation Common Stock (RGEN) vs Upwork Inc (UPWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Upwork Inc — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B), while Upwork Inc trades at $8.44 (market cap $1.08B). The key difference: Repligen Corporation Common Stock is far larger — about 10.3× Upwork Inc's market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, Upwork Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Upwork Inc for 38 Days on average.
| RGEN | UPWK | |
|---|---|---|
Market Cap | $11.14B | $1.08B |
Volume | 1,259,263 | 2,181,968 |
Sector | Health | Industrials |
52-Week High | $194.57 | $22.11 |
52-Week Low | $102.87 | $7.84 |
Typical Hold Time | 0 Days | 38 Days |
Enterprise Value | $11.02B | $842.37M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
UPWK trades at $8.43, down 2.09% today, with mixed technical signals showing bullish moving averages but overbought RSI levels. The company maintains strong profitability with 77.21% gross margins and 12.93% net income margin, though recent earnings showed two misses out of three quarters. Revenue growth has slowed from 28.02% in 2024 to 14.65% in 2025, with Q3 2026 earnings pending. Institutional buying interest exists with Bank of America acquiring 704,083 shares in September 2026.
UPWK presents a compelling value case with low P/E of 11.08 and P/S of 1.49, trading below the $9.64 consensus target. However, AI disruption to freelance markets and declining active client counts pose significant risks. The stock offers 14% upside to analyst targets but faces execution challenges amid industry transformation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Upwork Inc
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with highly-skilled independent professionals. The develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to Clients.
Read more on UPWK →
